Episode
GLP-1s for Employers: Navigating What’s Next
- Podcast
- The Granite List Live
- Published
- Jan 26, 2026
- Duration seconds
- 1000
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-granite-list-live-6598764/episodes/glp-1s-for-employers-navigating-what-s-next/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-granite-list-live-6598764/glp-1s-for-employers-navigating-what-s-next.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This week on The Granite List.Live, Sally is joined by Jessica Lea, PharmD and CEO of Tria Health, as they dive into the fast-changing landscape of GLP-1 medications for obesity and diabetes. Jessica shares her insight on why pharmacist-led oversight is important, especially with complex and costly drugs like Ozempic and Wegovy. Additionally, together, Sally and Jessica explore: Challenges employers face when deciding whether to cover these medications The impact of direct-to-consumer options The importance of combining medication with lifestyle changes for lasting results Future developments in GLP-1 treatments and their potential uses. Learn more about Tria Health on The Granite List!